The
summary says that, contrary to popular
opinion, Dr Wakefield was not the cause of
the MMR scare. Rather, his hypothesis
of a possible link between MMR and autism was
but one episode in a much longer public
health debate about vaccine safety. His
participation in this debate was
conscientious, reasonable and
responsible for a research doctor in his
position.
Dr
Wakefields work on MMR and his
connections with the lawyers Dawbarns and the
Legal Aid Board (now the Legal Services
Commission) were well known both in the
general media and amongst his colleagues from
an early stage.
Brian
Deer and his editors have a poor
understanding of Dr Wakefields patent
applications and the underlying science and
technology. In fact, Dr Wakefields
invention [a single measles vaccine combined
with a treatment, possibly a complete
cure for autism] could never
compete with MMR.
Brian
Deer and his editors have badly
misunderstood the quite separate nature and
purposes of the ethical approval
obtained at the Royal Free hospital, known as
172/96, a pilot study being performed for the
Legal Aid Board, and the paper published in
the Lancet in February 1998.
The
referral of children to the Royal Free
hospital was orthodox, reflecting
Dr Wakefields well-known interests, and
children were not recruited to
the study. When presented with a child
demonstrating regressive autism and bowel
symptoms the clinician is bound to
investigate the childs symptoms.
Beyond approving the use of data derived from
investigations ethics approval had
little or no material role to play.
Brian
Deer and his editors ignore altogether
that all clinical decisions and procedures
conducted in relation to children were by
Professor Walker-Smith and his team, in
relation to gastrointestinal investigations,
and by other appropriate specialist
paediatric practitioners in relation to, for
example, lumbar puncture.
Allegations
that the Royal Free hospital
laundered money from the Legal
Aid Board for Dr Wakefield's research benefit
are unfounded.
The
summary also made a number of other points.